286 related articles for article (PubMed ID: 29896297)
1. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity.
Liu L; Chen Q; Ruan C; Chen X; Zhang Y; He X; Zhang Y; Lu Y; Guo Q; Sun T; Wang H; Jiang C
Theranostics; 2018; 8(11):2974-2987. PubMed ID: 29896297
[TBL] [Abstract][Full Text] [Related]
2. Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.
Zhao K; Li D; Cheng G; Zhang B; Han J; Chen J; Wang B; Li M; Xiao T; Zhang J; Zhou D; Jin Z; Fan X
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683965
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle.
Cun X; Chen J; Li M; He X; Tang X; Guo R; Deng M; Li M; Zhang Z; He Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39545-39559. PubMed ID: 31617997
[TBL] [Abstract][Full Text] [Related]
5. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
6. In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity.
Shin H; Na K
Biomaterials; 2019 Mar; 197():32-40. PubMed ID: 30639548
[TBL] [Abstract][Full Text] [Related]
7. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
8. Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy.
Gao Z; He T; Zhang P; Li X; Zhang Y; Lin J; Hao J; Huang P; Cui J
ACS Appl Mater Interfaces; 2020 May; 12(18):20271-20280. PubMed ID: 32283924
[TBL] [Abstract][Full Text] [Related]
9. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
10. Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents.
Wong DY; Yeo CH; Ang WH
Angew Chem Int Ed Engl; 2014 Jun; 53(26):6752-6. PubMed ID: 24844571
[TBL] [Abstract][Full Text] [Related]
11. Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.
Parker JP; Ude Z; Marmion CJ
Metallomics; 2016 Jan; 8(1):43-60. PubMed ID: 26567482
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
13. Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy.
Shen S; Li HJ; Chen KG; Wang YC; Yang XZ; Lian ZX; Du JZ; Wang J
Nano Lett; 2017 Jun; 17(6):3822-3829. PubMed ID: 28488871
[TBL] [Abstract][Full Text] [Related]
14. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
[TBL] [Abstract][Full Text] [Related]
15. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
[TBL] [Abstract][Full Text] [Related]
16. Development of Platinum Complexes for Tumor Chemoimmunotherapy.
Jin S; Guo Y; Wang X
Chemistry; 2024 Feb; 30(10):e202302948. PubMed ID: 38171804
[TBL] [Abstract][Full Text] [Related]
17. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
Hu G; Chun X; Wang Y; He Q; Gao H
Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
20. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]